RecruitingNot ApplicableNCT05792930

Developing an Integrated Psychotherapy With Cognitive-behavioral Therapy and Biofeedback Therapy for Somatic Symptom Disorder

Developing an Integrated Psychotherapy With Cognitive-behavioral Therapy and Biofeedback Therapy for Somatic Symptom Disorder: a Randomized Controlled Trial


Sponsor

National Taiwan University Hospital

Enrollment

60 participants

Start Date

Jul 11, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This research program is aimed to develop a integrative psychotherapy (including CBT and biofeedback therapy) and to examine its efficacy on treatment of somatic symptom disorder. The study design is a randomized controlled trial with waiting list control. Scores of Patient Health Questionniare-15 and Health Anxiety Questionnaire are the primary endpoints.


Eligibility

Min Age: 20 YearsMax Age: 70 Years

Inclusion Criteria1

  • Patient with somatic symptom disorder (confirmed by psychiatrists)

Exclusion Criteria4

  • The age is younger than 20 or older than 70 years
  • Having psychotic symptoms or cognitive impairment
  • Having a potentially lethal illness
  • Cannot read the questionnaires by oneself

Interventions

BEHAVIORALcognitive-behavioral therapy and biofeedback therapy

Complete eight sessions of cognitive-behavioral therapy and biofeedback therapy within three months.


Locations(1)

Department of Psychiatry, National Taiwan University Hospital Yunlin Branch

Yunlin, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05792930


Related Trials